Last 11,850 KRW
Change Today +150.00 / 1.28%
Volume 84.3K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:20 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Seung-Ryel Baek

Vice Chairman and Chief Executive Officer, Daewon Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 1 different industries.

See Board Relationships
55--

Background*

Mr. Seung-Ryel Baek serves as the Chief Executive Officer of Daewon Pharmaceutical Co. Ltd., and has also been its Director since March 14, 2008. Mr. Baek served as President of Daewon Pharmaceutical Co. Ltd. He graduated at Seoul National University, majored in Agricultural Biology and Ph.D in Agriculture at Seoul National University.

Corporate Headquarters*

229-3 Yongdap Dong
Seoul, -- 133-850

South Korea

Phone: 82 2 2204 6971
Fax: 82 2 498 9108

Board Members Memberships*

2008-Present
Vice Chairman and Chief Executive Officer

Education*

Unknown/Other Education
Seoul National University
PhD
Seoul National University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 11,850.00 KRW +150.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.